Glipizide Tablet, Film Coated, Extended Release
Product Images NDC 70518-2308

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 70518-2308). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glipizide 2.5mg 70518 2308 00

Glipizide 2.5 mg extended-release film-coated tablets packaging label by RemedyRepack Inc. The label indicates a quantity of 30 tablets. It includes directions for use referencing the package insert, storage temperature guidelines, and manufacturer information for Rising Pharma, Inc. in Allendale, NJ.*

FDA Label Image

Structural Formula (Structural Formula)

Chemical structure diagram of Glipizide, showing its molecular framework with various rings, including a sulfonylurea group and a methyl-substituted pyrimidine ring, consistent with the active ingredient in the Glipizide medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.